articleTop 10% cited

Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention

American Journal of Kidney Diseases · 1996 · Vol. 27(3) · pp. 347–354

Adeera Levin✉(St. Paul's Hospital)Joel Singer(University of British Columbia)Christopher Thompson(University of British Columbia)Heather Ross(University of British Columbia)M. J. T. Lewis(University of British Columbia)

View via DOI Publisher page

Dialysis and Renal Disease Management Cardiovascular Function and Risk Factors Heart Failure Treatment and ManagementMedicineLeft ventricular hypertrophyCardiologyInternal medicineDialysisCreatininePopulationMuscle hypertrophyKidney diseaseRenal function

MeSH terms

AdultAgedAged, 80 and overBritish ColumbiaEchocardiographyFemaleRenal DialysisHumansKidney Failure, ChronicMaleMiddle AgedProspective StudiesComorbidityPrevalenceHypertrophy, Left Ventricular

Citations

712

FWCI

11.14

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

Kidney Disease as a Risk Factor for Development of Cardiovascular Disease